Literature DB >> 11857536

Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice.

Anita Boelen1, Joan Kwakkel, Marion Barends, Lia de Rond, Jan Dormans, Tjeerd Kimman.   

Abstract

RSV is an important cause of bronchiolitis in infants. Immunopathology may play a role in RSV-induced bronchiolitis and severe RSV-induced disease has been associated with a Th2 type immune response. The aim of the study was to identify cytokine pathways that are crucial in influencing RSV-induced disease. For that purpose we inoculated IFNgammaR-/-, IL-12-/-, IL-18-/-, or IL-4-/- mice with RSV. We observed that an RSV infection resulted in a predominant Th1 cytokine response associated with slight bronchiolitis and alveolitis. Pulmonary histopathology was only aggravated in IFN R-/- mice, characterised by eosinophilic influx around the bronchioles. Despite subtle changes in cytokine expression, no differences in histopathology were observed in IL-12-/- and IL-18-/- mice. Deficiency of IL-4 has no effect on RSV-induced Th1 cytokines and pulmonary histopathology. IFNgamma-receptor deficiency during primary RSV infection resulted in a disturbed Th1 response based on increased IL-4, IL-5, and IL-13 expression and the presence of eosinophils in the lungs. It is concluded that IFNgamma signalling is required for a pronounced Th1 response to RSV while IL-12 and IL-18 are not. A shift in the balance between Th1 and Th2 towards a Th2 response induced by missing IFNgamma signalling leads to aggravated pulmonary pathology. This is not caused by enhanced viral load. Copyright 2002 Wiley‐Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857536     DOI: 10.1002/jmv.2180

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.

Authors:  Annemieke Schuurhof; Louis Bont; Jeroen L A Pennings; Hennie M Hodemaekers; Piet W Wester; Annemarie Buisman; Lia C G H de Rond; Myra N Widjojoatmodjo; Willem Luytjes; Jan L L Kimpen; Riny Janssen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Host transcription profiles upon primary respiratory syncytial virus infection.

Authors:  Riny Janssen; Jeroen Pennings; Hennie Hodemaekers; Annemarie Buisman; Marijke van Oosten; Lia de Rond; Kemal Oztürk; Jan Dormans; Tjeerd Kimman; Barbara Hoebee
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 4.  Induction and function of virus-specific CD4+ T cell responses.

Authors:  Jason K Whitmire
Journal:  Virology       Date:  2011-01-14       Impact factor: 3.616

Review 5.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice.

Authors:  Stephanie F Glineur; Aaron B Bowen; Caroline M Percopo; Katia E Garcia-Crespo; Kimberly D Dyer; Sergei I Ochkur; Nancy A Lee; James J Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2014-08-28       Impact factor: 3.616

7.  Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.

Authors:  Katherine S Held; William G Glass; Yevgeniya I Orlovsky; Kimberly A Shamberger; Ted D Petley; Patrick J Branigan; Jill M Carton; Heena S Beck; Mark R Cunningham; Jacqueline M Benson; Thomas E Lane
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

Review 8.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

9.  Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.

Authors:  Elaine M Castilow; Matthew R Olson; David K Meyerholz; Steven M Varga
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Virally delivered cytokines alter the immune response to future lung infections.

Authors:  James Harker; Alexander Bukreyev; Peter L Collins; Belinda Wang; Peter J M Openshaw; John S Tregoning
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.